Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naive patients with rheumatoid arthritis

Kim Lauper; Denis Mongin; Florenzo Iannone; Eirik K. Kristianslund; Tore K. Kvien; Dan C. Nordström; Karel Pavelka; Manuel Pombo-Suarez; Ziga Rotar; Maria J. Santos; Catalin Codreanu; Galina Lukina; Sara L. Gale; Markus John; Yves Luder; Delphine S. Courvoisier; Cem Gabay

doi:10.1016/j.semarthrit.2019.06.020

Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naive patients with rheumatoid arthritis

Kim Lauper, Denis Mongin, Florenzo Iannone, Eirik K. Kristianslund, Tore K. Kvien, Dan C. Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ziga Rotar, Maria J. Santos, Catalin Codreanu, Galina Lukina, Sara L. Gale, Markus John, Yves Luder, Delphine S. Courvoisier, Cem Gabay

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Seminars in Arthritis and Rheumatism
Volym	50
Nummer	1
Sidor (från-till)	17-24
Antal sidor	8
ISSN	0049-0172
DOI	https://doi.org/10.1016/j.semarthrit.2019.06.020
Status	Publicerad - feb. 2020
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3121 Allmänmedicin, inre medicin och annan klinisk medicin

Åtkomst av dokument

10.1016/j.semarthrit.2019.06.020

1-s2.0-S0049017219302033-mainAccepterat manuskript från författare, 950 KBLicens: CC BY-NC-ND
1-s2.0-S0049017219302033-mainSlutlig publicerad version, 1,03 MBLicens: CC BY-NC-ND

Citera det här

Lauper, K., Mongin, D., Iannone, F., Kristianslund, E. K., Kvien, T. K., Nordström, D. C., Pavelka, K., Pombo-Suarez, M., Rotar, Z., Santos, M. J., Codreanu, C., Lukina, G., Gale, S. L., John, M., Luder, Y., Courvoisier, D. S., & Gabay, C. (2020). Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naive patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism, 50(1), 17-24. https://doi.org/10.1016/j.semarthrit.2019.06.020

@article{fdf13cdf285f4a7d91ede6a6d71c6e4d,

title = "Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naive patients with rheumatoid arthritis",

keywords = "3121 General medicine, internal medicine and other clinical medicine, Rheumatoid arthritis, Biological therapies, DMARDs, Tocilizumab, TNF inhibitors, Epidemiology, Monotherapy, SURVIVAL, MANAGEMENT, VALIDATION, DISCONTINUATION, THERAPY, DOUBLE-BLIND, REMISSION",

author = "Kim Lauper and Denis Mongin and Florenzo Iannone and Kristianslund, {Eirik K.} and Kvien, {Tore K.} and Nordstr{\"o}m, {Dan C.} and Karel Pavelka and Manuel Pombo-Suarez and Ziga Rotar and Santos, {Maria J.} and Catalin Codreanu and Galina Lukina and Gale, {Sara L.} and Markus John and Yves Luder and Courvoisier, {Delphine S.} and Cem Gabay",

year = "2020",

month = feb,

doi = "10.1016/j.semarthrit.2019.06.020",

language = "English",

volume = "50",

pages = "17--24",

journal = "Seminars in Arthritis and Rheumatism",

issn = "0049-0172",

publisher = "W B SAUNDERS CO-ELSEVIER INC",

number = "1",

}

Lauper, K, Mongin, D, Iannone, F, Kristianslund, EK, Kvien, TK, Nordström, DC, Pavelka, K, Pombo-Suarez, M, Rotar, Z, Santos, MJ, Codreanu, C, Lukina, G, Gale, SL, John, M, Luder, Y, Courvoisier, DS & Gabay, C 2020, 'Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naive patients with rheumatoid arthritis', Seminars in Arthritis and Rheumatism, vol. 50, nr. 1, s. 17-24. https://doi.org/10.1016/j.semarthrit.2019.06.020

Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naive patients with rheumatoid arthritis. / Lauper, Kim; Mongin, Denis; Iannone, Florenzo et al.

I: Seminars in Arthritis and Rheumatism, Vol. 50, Nr. 1, 02.2020, s. 17-24.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naive patients with rheumatoid arthritis

AU - Lauper, Kim

AU - Mongin, Denis

AU - Iannone, Florenzo

AU - Kristianslund, Eirik K.

AU - Kvien, Tore K.

AU - Nordström, Dan C.

AU - Pavelka, Karel

AU - Pombo-Suarez, Manuel

AU - Rotar, Ziga

AU - Santos, Maria J.

AU - Codreanu, Catalin

AU - Lukina, Galina

AU - Gale, Sara L.

AU - John, Markus

AU - Luder, Yves

AU - Courvoisier, Delphine S.

AU - Gabay, Cem

PY - 2020/2

Y1 - 2020/2

KW - 3121 General medicine, internal medicine and other clinical medicine

KW - Rheumatoid arthritis

KW - Biological therapies

KW - DMARDs

KW - Tocilizumab

KW - TNF inhibitors

KW - Epidemiology

KW - Monotherapy

KW - SURVIVAL

KW - MANAGEMENT

KW - VALIDATION

KW - DISCONTINUATION

KW - THERAPY

KW - DOUBLE-BLIND

KW - REMISSION

U2 - 10.1016/j.semarthrit.2019.06.020

DO - 10.1016/j.semarthrit.2019.06.020

M3 - Article

VL - 50

SP - 17

EP - 24

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 1

ER -

Lauper K, Mongin D, Iannone F, Kristianslund EK, Kvien TK, Nordström DC et al. Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naive patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism. 2020 feb.;50(1):17-24. Epub 2019 juni 28. doi: 10.1016/j.semarthrit.2019.06.020